Clinical Trial Update: A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial is investigating an MRD-based treatment strategy in children and young adults with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia Childhood

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Acute Myeloid Leukemia, Childhood | Phase 3 | Status: UNKNOWN